Cefazolin: Difference between revisions
m (Protected "Cefazolin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| Line 21: | Line 21: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
'''Cefazolin''' ([[International Nonproprietary Name|INN]]), also known as '''cefazoline''' or '''cephazolin''', is a first generation [[cephalosporin]] [[antibiotic]]. | '''Cefazolin''' ([[International Nonproprietary Name|INN]]), also known as '''cefazoline''' or '''cephazolin''', is a first generation [[cephalosporin]] [[antibiotic]]. | ||
| Line 46: | Line 46: | ||
[[Category:Cephalosporin antibiotics]] | [[Category:Cephalosporin antibiotics]] | ||
[[fr:Céfazoline]] | [[fr:Céfazoline]] | ||
Revision as of 23:35, 8 August 2012
| File:Cefazolin.png | |
| Clinical data | |
|---|---|
| Pregnancy category | |
| Routes of administration | Intravenous, intramuscular |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | NA |
| Metabolism | ? |
| Elimination half-life | 1.8 hours (given IV) 2 hours (given IM) |
| Excretion | Renal, unchanged |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C14H13N8O4S3 |
| Molar mass | 454.51 g/mol |
|
WikiDoc Resources for Cefazolin |
|
Articles |
|---|
|
Most recent articles on Cefazolin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Cefazolin at Clinical Trials.gov Clinical Trials on Cefazolin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Cefazolin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Cefazolin Discussion groups on Cefazolin Directions to Hospitals Treating Cefazolin Risk calculators and risk factors for Cefazolin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Cefazolin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Cefazolin (INN), also known as cefazoline or cephazolin, is a first generation cephalosporin antibiotic.
The drug is usually administrated either by intramuscular injection (injection into a large muscle) or intravenous infusion (intravenous fluid into a vein).
Indications
Cefazolin is mainly used to treat bacterial infections of the skin. It can also be used to treat moderately severe bacterial infections involving the lung, bone, joint, stomach, blood, heart valve, and urinary tract. It is clinically effective against infections caused by staphylococci and streptococci species of Gram positive bacteria. These organisms are common on normal human skin. Resistance to cefazolin is seen in several species of bacteria.
Side effects
Side effects from cefazolin are not common. Possible side effects include:
- diarrhea
- stomach pain
- upset stomach
- vomiting
Cefazolin is marketed under the following brand names: Ancef®, Cefacidal®, Cefamezin®, Cefrina®, Elzogram®, Faxilen®, Gramaxin®, Kefazol®, Kefol®, Kefzol®, Kefzolan®, Kezolin®, Novaporin®, and Zolicef®
External links
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Cephalosporin antibiotics